Transgenomic buys Clinical Data markers

Transgenomic has struck a deal to buy Clinical Data's genetic tests for heart disease along with the biomarkers needed for the PGxPredict tests for $15.4 million. The deal provides $6 million upfront with the rest in one-year and three-year promissory notes. Report

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.